Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 12, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Preoperative Corticosteroid Injection and Postoperative Infection Following De Quervain's Release: A National

Mikayla P Borusiewicz1, Thompson Zhuang1, David R Steinberg1

  • 1Hospital of the University of Pennsylvania, Philadelphia, USA.

Hand (New York, N.Y.)
|May 11, 2026
PubMed
Summary

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-articular Delivery of Recombinant Interleukin-1 Receptor Antagonist Protein (Anakinra) Enhances Graft Function in a Porcine Model of Osteochondral Repair.

The American journal of sports medicine·2026
Same author

Sustained Structural and Functional Deficits in the Porcine Knee Six Months Following Meniscus Destabilization.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2026
Same author

Artificial Intelligence Can Inform Prediction of American Society of Anesthesiologists Physical Status Classification in Hand Surgery.

Hand (New York, N.Y.)·2025
Same author

Sagittal and Coronal Plate Position Is Not Associated With Flexor Tendon Irritation, Rupture, or Need for Plate Removal After Volar Locking Plate Fixation of Distal Radius Fractures.

Hand (New York, N.Y.)·2025
Same author

Improved Risk Adjustment for Comorbid Diagnoses in Administrative Claims Analyses of Orthopaedic Surgery.

The Journal of bone and joint surgery. American volume·2025
Same author

Concurrent Perioperative Benzodiazepine and Opioid Utilization in Opioid-Naive Patients Undergoing Soft Tissue Hand Surgery.

Hand (New York, N.Y.)·2025

Corticosteroid injections before De Quervain's release surgery do not increase surgical site infection risk. This finding applies to injections given within 90 days, and even 60 days, prior to the procedure.

Area of Science:

  • Orthopedic Surgery
  • Musculoskeletal Disorders
  • Pharmacology

Background:

  • De Quervain's tenosynovitis is commonly treated with conservative measures including corticosteroid injections.
  • Surgery may be necessary for refractory cases, but the impact of prior injections on surgical outcomes is unknown.
  • This study investigates the potential link between corticosteroid injections and adverse outcomes following surgical release for De Quervain's tenosynovitis.

Purpose of the Study:

  • To determine if corticosteroid injections administered within 3 months before De Quervain's release surgery increase the risk of postoperative surgical site infection.
  • To assess the association between recent corticosteroid injections and other adverse surgical outcomes like reoperation or wound dehiscence.

Main Methods:

  • A national administrative database was used to identify adult patients who underwent De Quervain's release.
Keywords:
De Quervain’s tenosynovitisanatomycorticosteroiddiagnosisglucocorticoidinfectioninjectionoutcomesresearch & health outcomeswrist

Related Experiment Videos

Last Updated: May 12, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

  • Patients were categorized into two groups: those who received a corticosteroid injection within 90 days prior to surgery and those who did not.
  • Propensity score matching was employed to control for confounding variables, followed by assessment of surgical site infection, reoperation, and wound dehiscence rates.

    • Main Results:

    • No statistically significant increase in surgical site infections was observed in patients who received a corticosteroid injection within 90 days prior to surgery.
    • Rates of return to the operating room for infection and wound dehiscence were similar between the groups.
    • A sensitivity analysis confirmed no increased risk of surgical site infection when injections were given within 60 days before surgery.

    Conclusions:

    • Corticosteroid injections administered within 90 days prior to De Quervain's release surgery are not associated with an elevated risk of postoperative surgical site infection.
    • The findings extend to a 60-day window, indicating that recent corticosteroid injections do not compromise surgical site integrity or increase infection risk.
    • This suggests that corticosteroid injections can be safely administered prior to surgical intervention for De Quervain's tenosynovitis without compromising surgical outcomes.